Christian Brechot
Overview
Explore the profile of Christian Brechot including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
111
Citations
6062
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hammad N, Ransy C, Pinson B, Talmasson J, Brechot C, Rossignol J, et al.
Sci Rep
. 2024 Dec;
14(1):30679.
PMID: 39730386
Viruses are dependent on cellular energy metabolism for their replication, and the drug nitazoxanide (Alinia) was shown to interfere with both processes. Nitazoxanide is an uncoupler of mitochondrial oxidative phosphorylation...
2.
Moniaux N, Geoffre N, Deshayes A, Dos Santos A, Job S, Lacoste C, et al.
Hepatology
. 2024 Jul;
PMID: 38975812
Background And Aims: Antimicrobial proteins of the regenerating family member 3 alpha (REG3A) family provide a first line of protection against infections and transformed cells. Their expression is inducible by...
3.
Brechot C, Szekely Bjorndal A, Ewbank J
Science
. 2024 Mar;
383(6688):1187-1188.
PMID: 38484076
No abstract available.
4.
Zhang Y, Bourgine M, Wan Y, Song J, Li Z, Yu Y, et al.
J Hepatol
. 2023 Oct;
80(1):31-40.
PMID: 37827470
Background & Aims: Immunotherapy for chronic hepatitis B virus (HBV) infection has not yet demonstrated sufficient efficacy. We developed a non-integrative lentiviral-vectored therapeutic vaccine for chronic hepatitis B and tested...
5.
Perumal R, Shunmugam L, Naidoo K, Wilkins D, Garzino-Demo A, Brechot C, et al.
iScience
. 2023 Jun;
26(6):106935.
PMID: 37265584
As COVID-19 evolves from a pandemic to an endemic disease, the already staggering number of people that have been or will be infected with SARS-CoV-2 is only destined to increase,...
6.
Perumal R, Shunmugam L, Naidoo K, Abdool Karim S, Wilkins D, Garzino-Demo A, et al.
Front Immunol
. 2023 May;
14:1117464.
PMID: 37153597
Post-Acute Sequelae of Severe Acute Respiratory Syndrome Coronavirus - 2 (SARS-CoV-2) infection, or Long COVID, is a prevailing second pandemic with nearly 100 million affected individuals globally and counting. We...
7.
Roper R, Garzino-Demo A, Del Rio C, Brechot C, Gallo R, Hall W, et al.
Vaccine
. 2023 Apr;
41(20):3171-3177.
PMID: 37088603
The widespread outbreak of the monkeypox virus (MPXV) recognized in 2022 poses new challenges for public healthcare systems worldwide. With more than 86,000 people infected, there is concern that MPXV...
8.
Mishra S, Wang B, Jain S, Ding J, Rejeski J, Furdui C, et al.
Gut
. 2023 Mar;
72(10):1848-1865.
PMID: 36948576
Objective: Ample evidence exists for the role of abnormal gut microbiota composition and increased gut permeability ('leaky gut') in chronic inflammation that commonly co-occurs in the gut in both obesity...
9.
Gonzalez P, Dos Santos A, Darnaud M, Moniaux N, Rapoud D, Lacoste C, et al.
Commun Biol
. 2023 Mar;
6(1):269.
PMID: 36918710
Innate immune mediators of pathogen clearance, including the secreted C-type lectins REG3 of the antimicrobial peptide (AMP) family, are known to be involved in the regulation of tissue repair and...
10.
Chumakov K, Brechot C, Gallo R, Plotkin S
N Engl J Med
. 2023 Feb;
388(7):577-579.
PMID: 36779646
No abstract available.